Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.King Pharmaceuticals and Acura Pharmaceuticals have completed patient enrollment for the pivotal Phase III clinical trial evaluating Acurox tablets for relief of moderate to severe pain.
Subscribe to our email newsletter
The companies expect to report top-line results from this pivotal trial by July 2008 and submit a new drug application for Acurox tablets to the FDA before the end of 2008.
Eric Carter, chief science officer of King, said: “We expect that Acurox tablets will be the first approved immediate-release opioid analgesic designed to resist or deter common methods of prescription drug abuse.”